Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Innoviva Inc (INVA)

Innoviva Inc (INVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 893,222
  • Shares Outstanding, K 69,783
  • Annual Sales, $ 391,870 K
  • Annual Income, $ 265,850 K
  • 60-Month Beta 0.53
  • Price/Sales 3.15
  • Price/Cash Flow 2.79
  • Price/Book 1.41
Trade INVA with:

Options Overview Details

View History
  • Implied Volatility 42.22% ( +7.10%)
  • Historical Volatility 26.12%
  • IV Percentile 35%
  • IV Rank 29.98%
  • IV High 94.30% on 12/30/22
  • IV Low 19.91% on 09/08/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 24
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 1,026
  • Open Int (30-Day) 922

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.41
  • Number of Estimates 1
  • High Estimate 0.41
  • Low Estimate 0.41
  • Prior Year 0.55
  • Growth Rate Est. (year over year) -25.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.10 +5.83%
on 01/24/23
13.80 -7.25%
on 01/17/23
-0.47 (-3.54%)
since 01/03/23
3-Month
12.10 +5.83%
on 01/24/23
13.89 -7.85%
on 11/14/22
-0.26 (-1.99%)
since 11/03/22
52-Week
11.56 +10.68%
on 09/26/22
20.71 -38.18%
on 04/05/22
-2.60 (-16.88%)
since 02/03/22

Most Recent Stories

More News
Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities LLC

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 2.86 (-4.67%)
INVA : 12.80 (-1.23%)
Four Undervalued Healthcare Stocks for 2023

These four health care stocks could be undervalued: Pfizer Inc., Regeneron Pharmaceuticals Inc., Innoviva Inc. and Exelixis Inc.

EXEL : 17.55 (-0.34%)
NOV : 23.27 (+1.35%)
PFE : 44.06 (-0.63%)
REGN : 783.13 (+4.25%)
INVA : 12.80 (-1.23%)
Innoviva (INVA) Gains As Market Dips: What You Should Know

In the latest trading session, Innoviva (INVA) closed at $13.27, marking a +0.15% move from the previous day.

INVA : 12.80 (-1.23%)
Innoviva (INVA) Stock Moves -1.06%: What You Should Know

In the latest trading session, Innoviva (INVA) closed at $13.03, marking a -1.06% move from the previous day.

INVA : 12.80 (-1.23%)
Innoviva (INVA) Gains As Market Dips: What You Should Know

Innoviva (INVA) closed at $13.47 in the latest trading session, marking a +1.43% move from the prior day.

INVA : 12.80 (-1.23%)
3 Biotech Stocks to Buy for Under $20 Right Now

The need for more advanced biotech research and development has increased amid an aging population and growing medical needs. Investors' sentiment toward biotech stocks has improved significantly over...

CDTX : 1.5100 (+11.03%)
EXEL : 17.55 (-0.34%)
INVA : 12.80 (-1.23%)
Innoviva (INVA) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Innoviva (INVA) closed at $12.77, marking a -1.47% move from the previous day.

INVA : 12.80 (-1.23%)
Innoviva Announces FDA Acceptance and Priority Review of New Drug Application for Sulbactam-Durlobactam (SUL-DUR)

Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and other healthcare assets, today announced that the U.S. Food and Drug Administration (FDA)...

INVA : 12.80 (-1.23%)
Should Value Investors Buy Innoviva (INVA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

INVA : 12.80 (-1.23%)
MRK : 102.94 (-0.50%)
Zacks.com featured highlights PBF Energy, Innoviva, Global Partners, Heritage-Crystal Clean and Sterling Infrastructure

PBF Energy, Innoviva, Global Partners, Heritage-Crystal Clean and Sterling Infrastructure have been highlighted in this Screen of The Week article.

GLP : 38.39 (+0.97%)
STRL : 36.86 (+1.49%)
PBF : 39.60 (-0.90%)
HCCI : 37.82 (+0.75%)
INVA : 12.80 (-1.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance,...

See More

Key Turning Points

3rd Resistance Point 13.38
2nd Resistance Point 13.24
1st Resistance Point 13.02
Last Price 12.80
1st Support Level 12.66
2nd Support Level 12.52
3rd Support Level 12.30

See More

52-Week High 20.71
Fibonacci 61.8% 17.21
Fibonacci 50% 16.14
Fibonacci 38.2% 15.06
Last Price 12.80
52-Week Low 11.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar